SickKids scientists lay the groundwork for early detection of cardiomyopathy

In the first study to use whole genome sequencing to examine tandem repeat expansions in heart conditions, scientists at The Hospital for Sick Children (SickKids) have laid the groundwork for early detection of and future precision therapies for cardiomyopathy.

Senators Mull Ways to Stop Patent ‘Abuse’ by Pharma Companies

Senators and experts on Tuesday examined the range of tools that brand-name drug manufacturers have used to keep generic and biosimilar competition at bay —

May 22, 2024

Switching sales: Investigating the financial impacts of FDA’s priority vouchers – Pharmaceutical Technology

Share this article Priority review vouchers, which can be sold between pharma companies, slashes four months off an FDA review time for any drug application.

January 10, 2024

A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia

Monthly infusions of an investigational product that encapsulates dexamethasone sodium phosphate into autologous erythrocytes (EryDex) appeared safe but did not significantly improve neurological symptoms in

August 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.